Keyphrases
Acute Skin Reactions
25%
Acute Toxicity
25%
Adjuvant Chemotherapy
25%
Adjuvant Radiotherapy
25%
Anthracyclines
100%
Axillary Radiotherapy
25%
Axillary Surgery
25%
Baseline Characteristics
25%
Breast Cancer
25%
Cancer Research
25%
Chemoradiation
25%
Chemoradiotherapy
25%
Chemotherapy
25%
Chemotherapy Completion
25%
Chemotherapy Regimen
25%
Confidence Interval
50%
Disease-free Survival
25%
Early Breast Cancer
100%
Hazard Ratio
50%
Intention-to-treat
25%
Late Effects
25%
Local Control
25%
Local Recurrence
25%
Local Recurrence Rate
75%
No Significant Difference
50%
Optimal Sequence
25%
Permuted Block
25%
Phase II Trial
25%
Radiotherapy
25%
Radiotherapy Boost
25%
Radiotherapy Planning
25%
Randomized Phase III Trial
100%
Rate Difference
25%
Sequential Chemoradiotherapy
100%
Sequential Radiotherapy
25%
Severe Acute
25%
Subgroup Analysis
25%
Telangiectasia
25%
Time to Local Recurrence
25%
Medicine and Dentistry
Acute Toxicity
25%
Adjuvant Chemotherapy
25%
Adjuvant Radiotherapy
25%
Adverse Effect
25%
Anthracycline
100%
Arm
75%
Axillary Surgery
25%
Breast Cancer
100%
Cancer Research
25%
Chemoradiotherapy
100%
Chemotherapy
25%
Disease Free Survival
25%
Hazard Ratio
50%
Intention-to-Treat Analysis
25%
Phase III Trials
100%
Radiation Therapy
100%
Recurrence Risk
75%
Recurrent Disease
50%
Skin Manifestation
25%
Subgroup Analysis
25%
Telangiectasia
25%
Nursing and Health Professions
Acute Toxicity
25%
Adjuvant Chemotherapy
25%
Adjuvant Radiotherapy
25%
Anthracycline
100%
Breast Cancer
100%
Cancer Research
25%
Chemoradiotherapy
100%
Confidence Interval
50%
Disease Free Survival
25%
Hazard Ratio
50%
Intention to Treat Analysis
25%
Radiotherapy
100%
Randomization
25%
Recurrence Risk
75%
Recurrent Disease
50%
Skin Manifestation
25%
Telangiectasia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Toxicity
25%
Anthracycline
100%
Breast Cancer
100%
Chemoradiation Therapy
100%
Chemotherapy
100%
Disease Free Survival
25%
Malignant Neoplasm
25%
Phase III Trials
100%
Recurrence Risk
75%
Recurrent Disease
50%
Skin Manifestation
25%
Telangiectasia
25%
Neuroscience
Adverse Effect
12%
Anthracycline
50%
Chemotherapy Regimens
12%
Radiation Therapy
100%
Telangiectasia
12%
Immunology and Microbiology
Arm
100%
Disease Free Survival
33%